Zhaoxia Wang Selected Research

Zhaoxia Wang Research Topics

Disease

55	Neoplasms (Cancer) 06/2022 - 01/2010
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022 - 06/2012
12	MELAS Syndrome (Syndrome, MELAS) 01/2021 - 07/2002
9	Muscular Diseases (Myopathy) 01/2022 - 04/2014
8	Inflammation (Inflammations) 09/2022 - 01/2010
8	Adenocarcinoma of Lung 01/2021 - 04/2006
8	Carcinogenesis 01/2021 - 02/2013
7	Mitochondrial Diseases (Mitochondrial Disease) 09/2022 - 01/2014
6	Stomach Neoplasms (Stomach Cancer) 01/2021 - 11/2016
6	Hepatocellular Carcinoma (Hepatoma) 08/2019 - 05/2014
6	Colorectal Neoplasms (Colorectal Cancer) 10/2017 - 10/2011
5	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2013
5	Lung Neoplasms (Lung Cancer) 01/2021 - 11/2019
5	Ovarian Neoplasms (Ovarian Cancer) 11/2020 - 05/2013
5	Mitochondrial Encephalomyopathies (Mitochondrial Encephalomyopathy) 01/2019 - 07/2002
5	Stroke (Strokes) 01/2019 - 12/2010
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
4	Breast Neoplasms (Breast Cancer) 04/2019 - 02/2013
3	Neuronal intranuclear inclusion disease 01/2022 - 11/2019
3	Hypertension (High Blood Pressure) 01/2022 - 03/2016
3	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 05/2013
3	Chronic Progressive External Ophthalmoplegia (Progressive External Ophthalmoplegia) 01/2022 - 08/2013
3	Multiple System Atrophy 01/2022 - 01/2021
3	Hypoxia (Hypoxemia) 12/2021 - 05/2014
3	Myopathy with Abnormal Lipid Metabolism 12/2020 - 02/2014
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2020 - 04/2014
3	Muscular Dystrophies (Muscular Dystrophy) 11/2019 - 04/2014
3	Carcinoma (Carcinomatosis) 10/2019 - 01/2010
3	Adenocarcinoma 07/2019 - 11/2013
3	Obesity 08/2015 - 01/2010
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 05/2015
2	Sarcoglycanopathies 01/2022 - 01/2019
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022 - 11/2020
2	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 01/2022 - 01/2021
2	Oculopharyngodistal Myopathy 01/2022 - 01/2021
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2021
2	Myocardial Infarction 09/2021 - 06/2021
2	Ischemic Stroke 09/2021 - 03/2009
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 03/2021 - 01/2021
2	Type 2K Charcot-Marie-Tooth disease 01/2021 - 08/2017
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 11/2019
2	Neuroinflammatory Diseases 01/2021 - 01/2019
2	Polyneuropathies (Polyneuropathy) 01/2021 - 01/2017
2	Muscle Weakness 12/2020 - 11/2020

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 09/2022 - 04/2011
22	Long Noncoding RNAIBA 03/2022 - 01/2013
13	Mitochondrial DNA (mtDNA)IBA 09/2022 - 07/2002
12	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2015
10	Biological ProductsIBA 06/2022 - 01/2013
9	CytokinesIBA 09/2022 - 01/2010
9	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 04/2006
9	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2014
7	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
7	AntibodiesIBA 03/2021 - 07/2006
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016 - 01/2010
6	RNA (Ribonucleic Acid)IBA 01/2022 - 11/2016
5	Oxygen (Dioxygen)IBA 12/2021 - 12/2012
5	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 05/2014
5	Peptides (Polypeptides)IBA 12/2017 - 01/2010
4	Gefitinib (Iressa)FDA Link 03/2022 - 01/2020
4	ErbB Receptors (EGF Receptor)IBA 10/2020 - 01/2014
3	ChromatinIBA 06/2022 - 01/2013
3	Small Nucleolar RNA (snoRNA)IBA 03/2022 - 10/2017
3	5' Untranslated Regions (5' UTR)IBA 01/2022 - 11/2019
3	Prealbumin (Transthyretin)IBA 01/2022 - 01/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2020
3	Therapeutic UsesIBA 01/2022 - 11/2012
3	Riboflavin (Vitamin B2)FDA LinkGeneric 12/2020 - 02/2014
3	Tyrosine Kinase InhibitorsIBA 10/2020 - 01/2014
3	Signal Recognition ParticleIBA 01/2020 - 04/2014
3	Nicotine FDA Link 04/2019 - 02/2006
3	Messenger RNA (mRNA)IBA 01/2019 - 11/2013
3	NucleotidesIBA 01/2018 - 02/2007
3	IntegrinsIBA 12/2017 - 02/2016
3	Advanced Glycation End ProductsIBA 08/2017 - 01/2012
3	EnzymesIBA 12/2016 - 11/2011
3	LipidsIBA 12/2015 - 02/2007
3	Scorpion Venoms (Scorpion Venom)IBA 07/2011 - 01/2010
2	polyglycineIBA 01/2022 - 01/2021
2	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2022 - 04/2014
2	Sarcoglycans (beta Sarcoglycan)IBA 01/2022 - 01/2019
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 03/2016
2	Adenosine Triphosphate (ATP)IBA 12/2021 - 01/2020
2	Contrast MediaIBA 12/2021 - 05/2019
2	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 01/2019
2	Angiotensin IIIBA 01/2021 - 03/2016
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2016
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2020 - 05/2014
2	Immunologic Factors (Immunomodulators)IBA 11/2020 - 09/2020
2	Interleukin-6 (Interleukin 6)IBA 09/2020 - 01/2020
2	Docetaxel (Taxotere)FDA Link 05/2020 - 01/2010
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2020 - 01/2010
2	TensinsIBA 01/2020 - 05/2014
2	AntioxidantsIBA 01/2020 - 01/2018
2	Competitive Endogenous RNAIBA 01/2020 - 01/2018
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 05/2014

Therapy/Procedure

21	Therapeutics 06/2022 - 11/2012
11	Drug Therapy (Chemotherapy) 01/2021 - 01/2010
2	Immunotherapy 11/2021 - 10/2019
2	Precision Medicine 10/2019 - 10/2016